World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
41307
World Ranking
15859
National Ranking
600

Sjoerd Rodenhuis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sjoerd Rodenhuis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 329 publications — 23rd percentile

23% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sjoerd Rodenhuis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sjoerd Rodenhuis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Sjoerd Rodenhuis is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research primarily spans the field of Medicine, with a focus on several subfields including Epidemiology, Oncology, Pathology and Forensic Medicine, Surgery, and Cancer Research.

Their academic work covers main topics such as:

  • Cervical Cancer and HPV Research
  • Genetic factors in colorectal cancer
  • Colorectal and Anal Carcinomas
  • Breast Cancer Treatment Studies
  • Cancer Treatment and Pharmacology
  • HER2/EGFR in Cancer Research

Rodenhuis has contributed to a number of publications, with recent papers including:

  • Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site (2020) in British Journal of Cancer
  • Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer (2020) in UNC Libraries
  • Correction to: Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site (2023) in British Journal of Cancer

The frequent coauthors collaborating with Rodenhuis include:

  • Maud Kamal
  • Sonia Lameiras
  • Marc Deloger
  • Adeline Morel
  • Sophie Vacher

The primary venues for their research publications have been:

  • British Journal of Cancer
  • UNC Libraries

Best Publications

  • Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

    O. Abe;R. Abe;K. Enomoto;K. Kikuchi

  • A Gene-Expression Signature as a Predictor of Survival in Breast Cancer

    Marc J. van de Vijver;Yudong D. He;Laura J. van 't Veer;Hongyue Dai

  • Impairment of Cognitive Function in Women Receiving Adjuvant Treatment for High-Risk Breast Cancer: High-Dose Versus Standard-Dose Chemotherapy

    F.S.A.M. van Dam;S.B. Schagen;M.J. Muller;W. Boogerd

  • Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

    S Rodenhuis;M L van de Wetering;W J Mooi;S G Evers

  • Incidence and Possible Clinical Significance of K- ras Oncogene Activation in Adenocarcinoma of the Human Lung

    S. Rodenhuis;R. J. C. Slebos;A. J. M. Boot;S. G. Evers

  • Imatinib mesylate (STI-571 Glivec, Gleevec) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target. Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study.

    J Verweij;A van Oosterom;J.-Y Blay;I Judson

  • Clinical Pharmacokinetics of Cyclophosphamide

    Milly E de Jonge;Alwin D R Huitema;Sjoerd Rodenhuis;Jos H Beijnen

  • Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial

    A. Le Cesne;J.Y. Blay;I. Judson;A. Van Oosterom

  • Clinical significance of ras oncogene activation in human lung cancer.

    Sjoerd Rodenhuis;Robert J. C. Slebos

  • Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

    I F Faneyte;J G Schrama;J L Peterse;P L Remijnse

  • Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement

    Sjoerd Rodenhuis;Dick J. Richel;Elsken Van Der Wall;Jan H. Schornagel

  • Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

    Paul C Lorigan;Jaap Verweij;Zsuzsa Papai;Sjoerd Rodenhuis

  • Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)

    Jolien M. Bueno-de-Mesquita;Wim H. van Harten;Valesca P. Retel;Laura J. van't Veer

  • Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype

    Claudette E. Loo;Marieke E. Straver;Sjoerd Rodenhuis;Sara H. Muller

  • The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer

    Marieke E. Straver;Annuska M. Glas;Juliane Hannemann;Jelle Wesseling

  • High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer

    Sjoerd Rodenhuis;Marijke Bontenbal;Louk V.A.M. Beex;John Wagstaff

  • Randomized phase III study comparing conventional-dose doxorubicin plus ifosfamide versus high-dose doxorubicin plus ifosfamide plus recombinant human granulocyte-macrophage colony-stimulating factor in advanced soft tissue sarcomas: A trial of the European Organization for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group.

    A. Le Cesne;I. Judson;D. Crowther;S. Rodenhuis

  • Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients

    S. B. Schagen;M. J. Muller;W. Boogerd;R. M. Rosenbrand

  • Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).

    Stefan Sleijfer;Monia Ouali;Martine van Glabbeke;Anders Krarup-Hansen

  • Relationship between K-ras oncogene activation and smoking in adenocarcinoma of the human lung.

    R J Slebos;R H Hruban;O Dalesio;W J Mooi

Frequent Co-Authors

Jos H. Beijnen
Jos H. Beijnen Utrecht University
Jelle Wesseling
Jelle Wesseling Leiden University Medical Center
Emiel J. Th. Rutgers
Emiel J. Th. Rutgers Antoni van Leeuwenhoek Hospital
Jan H.M. Schellens
Jan H.M. Schellens Utrecht University
Lodewyk F. A. Wessels
Lodewyk F. A. Wessels Antoni van Leeuwenhoek Hospital
Johannes L. Peterse
Johannes L. Peterse Antoni van Leeuwenhoek Hospital
Marc J. van de Vijver
Marc J. van de Vijver University of Amsterdam
Elisabeth G.E. de Vries
Elisabeth G.E. de Vries University Medical Center Groningen
Emile E. Voest
Emile E. Voest Antoni van Leeuwenhoek Hospital
Hilde Rosing
Hilde Rosing Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine or healthcare opens up a variety of academic and professional pathways—many of which can now be started online. For registered nurses looking to boost their qualifications, enrolling in the cheapest rn to bsn program online can be a smart, cost-effective step toward advancing your career.

If you hold a non-nursing bachelor’s degree but want to make a rapid transition into nursing, consider pursuing a non nursing bachelor's to msn online program. These programs are designed for career-changers eager to enter the nursing field efficiently and effectively.

Students who prefer clear, direct access to a nursing career may benefit from direct admit nursing programs, which streamline the path into clinical education for eligible applicants.

For those interested in the administrative side of healthcare, enrolling in one of the best medical billing and coding schools online with financial aid options can provide a flexible and in-demand career pathway.

Best Scientists Citing Sjoerd Rodenhuis

Trending Scientists

Recently Published Articles